Immune Adjuvant Effect of Eukaryotic Expression Vector with Interleukin-2 on Hepatitis B Gene Vaccine

杜德伟,刘清泉,陈红梅,李谨革,连建奇,冯志华,周永兴,姚志强
DOI: https://doi.org/10.3969/j.issn.1001-2478.2001.02.005
2001-01-01
Abstract:BALB/c mice(H 2 d) were immunized by intramuscular injections with HBV S gene vaccine(pCR3 1 S) or coimmunized with eukaryotic expression vector with IL 2 The anti HBs levels in sera of mice were detected by ELISA and the HBsAg specific cytotoxic T lymphocyte(CTL) activities determined with 51 chromium release assay Eight weeks after immunization,the serum 450nm A values of single immunization with HBV S DNA vaccine and the co immunization with IL 2 vaccine were 1 24±0 1 and 1 98±0 17 respectively The cytolytic activies of CTL of these two groups of vaccines were (50 5±6 4)% and (61 9±7 1)% respectively When the spleen cells of the respective mice were treated with anti CD4 McAb,the cytolytic activities of CTL dropped to (48 3±5 9)% and (56 2±1 3)%,and those treated with anti CD8 McAb dropped to (10 6±1 4)% and (13 6±1 3)% respectively The results of this experiment indicated that the strong immunogenicity in humoral and cellular immunity could be promoted by vector coding murine IL 2,and the cytolytic activities of spleen cells of the immunized mice could be influenced when these cells were treated with anti CD4 or anti CD8 McAb Thus,the HBV DNA vaccine may be useful for both prophylactic and therapeutic purposes
What problem does this paper attempt to address?